No matter when or how often you get Botox, your skin keeps getting thinner over time, and Botox doesn’t slow that down.
Scientific Claim
In a 15-year computational simulation, dermal thickness declines progressively from approximately 1.89 mm to 1.75 mm across all botulinum toxin A treatment groups, with no meaningful difference observed between age at initiation (20–30, 31–40, 41–50 years) or injection frequency (biannual vs. triannual).
Original Statement
“Dermal thickness declined progressively, from ~1.89 mm in the youngest cohort at baseline to ~1.75 mm by year 15, with minimal differences between treatment frequencies.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim describes simulated model outputs with precise numerical values and no causal inference about human biology; definitive language is valid for the computational behavior.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether long-term BoNTA use alters the rate of dermal thinning compared to no treatment in humans.
Whether long-term BoNTA use alters the rate of dermal thinning compared to no treatment in humans.
What This Would Prove
Whether long-term BoNTA use alters the rate of dermal thinning compared to no treatment in humans.
Ideal Study Design
Meta-analysis of 15+ year longitudinal studies using high-resolution ultrasound or OCT to measure dermal thickness in 10,000+ adults with documented BoNTA use versus controls, stratified by age at initiation and injection frequency.
Limitation: Inconsistent measurement techniques across studies may introduce heterogeneity.
Longitudinal Cohort StudyLevel 2bNatural rate of dermal thinning over 15 years in individuals receiving regular BoNTA versus those who do not.
Natural rate of dermal thinning over 15 years in individuals receiving regular BoNTA versus those who do not.
What This Would Prove
Natural rate of dermal thinning over 15 years in individuals receiving regular BoNTA versus those who do not.
Ideal Study Design
Prospective cohort of 1,000 adults aged 25–45, with annual dermal thickness measurements via ultrasound for 15 years, comparing those receiving biannual/triannual BoNTA to untreated controls, adjusting for UV exposure and BMI.
Limitation: Cannot control for concurrent use of topical retinoids or fillers.
Randomized Controlled TrialLevel 1bCausal effect of BoNTA on dermal thickness over time.
Causal effect of BoNTA on dermal thickness over time.
What This Would Prove
Causal effect of BoNTA on dermal thickness over time.
Ideal Study Design
Double-blind RCT of 300 adults aged 30–40 randomized to biannual BoNTA, triannual BoNTA, or placebo for 15 years, with primary endpoint: change in dermal thickness measured by high-frequency ultrasound at year 15.
Limitation: Ethical and practical barriers to 15-year blinding and compliance.
In Vitro Fibroblast StudyLevel 5Whether BoNTA directly affects fibroblast function and collagen production over repeated exposure.
Whether BoNTA directly affects fibroblast function and collagen production over repeated exposure.
What This Would Prove
Whether BoNTA directly affects fibroblast function and collagen production over repeated exposure.
Ideal Study Design
Long-term (12-month) culture of human dermal fibroblasts exposed to repeated low-dose BoNTA (mimicking clinical dosing) versus control, measuring collagen I/III mRNA, protein synthesis, and senescence markers.
Limitation: Does not replicate in vivo mechanical or vascular microenvironment of skin.
Evidence from Studies
Supporting (1)
A 15-Year Computational Twin Modeling Study of Botulinum Toxin A Frequency and Age-Related Facial Aging.
The study used computer models to see if getting Botox at different ages or more often makes your skin age differently—turns out, it doesn’t. Everyone’s skin got thinner the same way over 15 years, no matter when or how often they got treated.